Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA

被引：12

作者：

Psimadas, Dimitrios ^{[1
]}

Valotassiou, Varvara ^{[1
]}

Alexiou, Sotiria ^{[1
]}

Tsougos, Ioannis ^{[1
]}

Georgoulias, Panagiotis ^{[1
]}

机构：

[1] Univ Thessaly, Sch Med, Univ Hosp Larissa, Dept Nucl Med, Larisa, Greece

来源：

CANCER INVESTIGATION | 2018年 / 36卷 / 02期

关键词：

Antibodies; radiolabeling; PSMA; prostate cancer; LU-177-PSMA-617 RADIOLIGAND THERAPY; METASTATIC PROSTATE-CANCER; MEMBRANE ANTIGEN PSMA; MONOCLONAL-ANTIBODY J591; IN-VIVO; PRECLINICAL EVALUATION; EXTRACELLULAR DOMAIN; RADIATION-DOSIMETRY; INHIBITORS; TUMORS;

D O I：

10.1080/07357907.2018.1430816

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine. The use of the exciting and attractive properties of radioisotopes for imaging and therapy has made Nuclear Medicine very significant when it comes to molecular imaging/therapy. Monoclonal Antibodies (mAbs) on the other hand are very important targeting biomolecules with high affinity that can "carry" the radioisotope of choice. Herein we make a brief overview of the radiolabeled mAbs that target prostate specific membrane antigen (PSMA) and their use in the management of patients with prostate cancer (PCa).

引用

页码：118 / 128

页数：11

共 50 条

[21] Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras
Jiao, Yuying
Xu, Peng
Luan, Sha
Wang, Xinyu
Gao, Yue
Zhao, Changjiu
Fu, Peng
NUCLEAR MEDICINE AND BIOLOGY, 2022, 104 : 28 - 37
[22] Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
Edward K. Fung
Sarah M. Cheal
Shoaib B. Fareedy
Blesida Punzalan
Volkan Beylergil
Jawaria Amir
Sandhya Chalasani
Wolfgang A. Weber
Daniel E. Spratt
Darren R. Veach
Neil H. Bander
Steven M. Larson
Pat B. Zanzonico
Joseph R. Osborne
EJNMMI Research, 6
[23] Low-Level Endogenous PSMA Expression in Nonprostatic Tumor Xenografts Is Sufficient for In Vivo Tumor Targeting and Imaging
Nimmagadda, Sridhar
Pullambhatla, Mrudula
Chen, Ying
Parsana, Princy
Lisok, Ala
Chatterjee, Samit
Mease, Ronnie
Rowe, Steven P.
Lupold, Shawn
Pienta, Kenneth J.
Pomper, Martin G.
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 486 - 493
[24] A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
Chen, Ying
Minn, Il
Rowe, Steven P.
Lisok, Alla
Chatterjee, Samit
Brummet, Mary
Banerjee, Sangeeta Ray
Mease, Ronnie C.
Pomper, Martin G.
BIOMOLECULES, 2022, 12 (03)
[25] Tumor-targeting Peptides: Ligands for Molecular Imaging and Therapy
Zhao, Ning
Qin, Yeshan
Liu, Hongguang
Cheng, Zhen
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (01) : 74 - 86
[26] Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer
Derks, Yvonne H. W.
van Lith, Sanne A. M.
Amatdjais-Groenen, Helene I., V
Wouters, Lieke W. M.
Kip, Annemarie
Franssen, Gerben M.
Laverman, Peter
Lowik, Dennis W. P. M.
Heskamp, Sandra
Rijpkema, Mark
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (07) : 2425 - 2435
[27] Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer
Murce, Erika
Beekman, Savanne
Spaan, Evelien
Handula, Maryana
Stuurman, Debra
de Ridder, Corrina
Seimbille, Yann
MOLECULES, 2023, 28 (10):
[28] Targeting NCA-95 and other granulocyte antigens and receptors with radiolabeled monoclonal antibodies (Mabs)
Meller, J.
Liersch, T.
Oezerden, M. M.
Sahlmann, C. -O.
Meller, B.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (06): : 582 - 598
[29] Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting Properties
Mitran, Bogdan
Tolmachev, Vladimir
Orlova, Anna
CURRENT MEDICINAL CHEMISTRY, 2020, 27 (41) : 7090 - 7111
[30] PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues
Hoshi, Seiji
Yaginuma, Kei
Meguro, Satoru
Onagi, Akifumi
Matsuoka, Kanako
Hata, Junya
Sato, Yuichi
Akaihata, Hidenori
Kataoka, Masao
Ogawa, Soichiro
Uemura, Motohide
Kojima, Yoshiyuki
CURRENT ONCOLOGY, 2023, 30 (08) : 7286 - 7302

← 1 2 3 4 5 →